XML 29 R80.htm IDEA: XBRL DOCUMENT v2.4.0.6
(Loss) Earnings Per Share (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                      
Net (loss) attributable to Exide Technologies $ (87,580) $ (15,443) $ (13,878) $ (106,498) $ (2,696) $ 68,215 $ (3,588) $ (5,192) $ (223,399) $ 56,739 $ 26,443
Basic weighted average shares outstanding                 77,270 77,667 76,678
Effect of dilutive securities:                      
Floating Rate Convertible Senior Subordinated Notes                 0 3,697 3,697
Adjustment to basic weighted average shares outstanding                 0 4,414 4,631
Diluted weighted average shares outstanding                 77,270 82,081 81,309
Basic earnings per share $ (1.49) $ (0.20) $ 0.18 $ (1.38) $ (0.03) $ 0.88 $ (0.05) $ (0.07) $ (2.89) $ 0.73 $ 0.34
Diluted earnings per share $ (1.49) $ (0.20) $ 0.18 $ (1.38) $ (0.03) $ 0.84 $ (0.05) $ (0.07) $ (2.89) $ 0.69 $ 0.33
Antidilutive securities excluded from computation of earnings per share                      
Total shares excluded                 8,071    
Shares associated with convertible debt (assumed conversion)
                     
Antidilutive securities excluded from computation of earnings per share                      
Total shares excluded                 3,697    
Employee stock options
                     
Effect of dilutive securities:                      
Incremental common shares                 0 292 619
Antidilutive securities excluded from computation of earnings per share                      
Total shares excluded                 2,872 1,800 1,500
Restricted stock awards (non-vested)
                     
Effect of dilutive securities:                      
Incremental common shares                 0 425 315
Antidilutive securities excluded from computation of earnings per share                      
Total shares excluded                 1,502